Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 162

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Prevalence of breast cancer treatment sequelae over 6 years of follow‐up: The Pulling Through Study

Open access
Schmitz, Kathryn H., Speck, Rebecca M., Rye, Sheree A., DiSipio, Tracey, Hayes, Sandra C.·2012·Cancer

Abstract

BACKGROUND: There is a need to better describe and understand the prevalence of breast cancer treatment‐related adverse effects amenable to physical therapy and rehabilitative exercise. Prior studies have been limited to single issues and lacked long‐term follow‐up. The Pulling Through Study provides data on prevalence of adverse effects in breast cancer survivors followed over 6 years. METHODS: A population‐based sample of Australian women (n = 287) diagnosed with invasive, unilateral breast cancer was followed for a median of 6.6 years and prospectively assessed for treatment‐related complications at 6, 12, and 18 months and 6 years after diagnosis. Assessments included postsurgical complications, skin or tissue reaction to radiation therapy, upper‐body symptoms, lymphedema, 10% weight gain, fatigue, and upper‐quadrant function. The proportion of women with positive indication for each complication and 1 or more complication was estimated using all available data at each time point. Women were only considered to have a specific complication if they reported the highest 2 levels of the Likert scale for self‐reported issues. RESULTS: At 6 years after diagnosis, more than 60% of women experienced 1 or more side effects amenable to rehabilitative intervention. The proportion of women experiencing 3 or more side effects decreased throughout follow‐up, whereas the proportion experiencing no side effects remained stable around 40% from 12 months to 6 years. Weight gain was the only complication to increase in prevalence over time. CONCLUSIONS: These data support the development of a multidisciplinary prospective surveillance approach for the purposes of managing and treating adverse effects in breast cancer survivors. Cancer 2012;118(8 suppl):. © 2012 American Cancer Society.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/cncr.27474

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 162

Metadata

Authors
Schmitz, K. H., Speck, R. M., Rye, S. A., DiSipio, T., & Hayes, S. C.
Venue
Cancer
Publisher
Wiley
Published
2012-04-06
Volume
118
Issue
S8
Pages
2217-2225
ISSN
  • 0008-543X
  • 1097-0142
OpenAlex
W1816371193
Cited by
162
References
3
FWCI
6.39
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prevalence of breast cancer treatment sequelae over 6 years of follow‐up: The Pulling Through Study. https://app.cochat.ai/papers/10.1002/cncr.27474
The paper
Schmitz, K. H., Speck, R. M., Rye, S. A., DiSipio, T., & Hayes, S. C. (2012). Prevalence of breast cancer treatment sequelae over 6 years of follow‐up: The Pulling Through Study. Cancer. https://doi.org/10.1002/cncr.27474

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.